Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$988.6K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 9 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 26 most recent Form 4 transactions.
| PCVX |
| Vaxcyte, Inc. |
| FTAX |
| 243 |
| $60.74 |
| $14.8K |
| -0.8% |
| Open the original filing on SEC.gov |
| Apr 7 | PCVX | Vaxcyte, Inc. | MEXER◷◆ | 3,000 | — | — | — | Open the original filing on SEC.gov |
| Apr 7 | PCVX | Vaxcyte, Inc. | SSELL◷ | 3,000 | $60.00 | $180K | -9.4% | Open the original filing on SEC.gov |
| Apr 7 | PCVX | Vaxcyte, Inc. | MEXER◷ | 3,000 | $25.92 | $77.8K | +10.3% | Open the original filing on SEC.gov |
| Mar 17 | PCVX | Vaxcyte, Inc. | SSELL◷ | 405 | $56.26 | $22.8K | -1.4% | Open the original filing on SEC.gov |
| Mar 17 | PCVX | Vaxcyte, Inc. | SSELL◷ | 1,487 | $55.39 | $82.4K | -4.8% | Open the original filing on SEC.gov |
| Mar 11 | PCVX | Vaxcyte, Inc. | MEXER◷◆ | 2,500 | — | — | — | Open the original filing on SEC.gov |
| Mar 11 | PCVX | Vaxcyte, Inc. | SSELL◷ | 2,500 | $58.59 | $146.5K | -7.5% | Open the original filing on SEC.gov |
| Mar 11 | PCVX | Vaxcyte, Inc. | MEXER◷ | 2,500 | $25.92 | $64.8K | +8.1% | Open the original filing on SEC.gov |
| Mar 9 | PCVX | Vaxcyte, Inc. | FTAX◷ | 495 | $59.32 | $29.4K | -1.6% | Open the original filing on SEC.gov |
| Mar 2 | PCVX | Vaxcyte, Inc. | FTAX | 326 | $61.98 | $20.2K | -1.0% | Open the original filing on SEC.gov |
| Feb 28 | PCVX | Vaxcyte, Inc. | FTAX | 243 | $61.98 | $15.1K | -0.8% | Open the original filing on SEC.gov |
| Feb 26 | PCVX | Vaxcyte, Inc. | MEXER◆ | 7,716 | — | — | — | Open the original filing on SEC.gov |
| Feb 26 | PCVX | Vaxcyte, Inc. | AGRANT◆ | 17,855 | — | — | — | Open the original filing on SEC.gov |
| Feb 26 | PCVX | Vaxcyte, Inc. | MEXER | 7,716 | $25.92 | $200K | +31.9% | Open the original filing on SEC.gov |
| Feb 26 | PCVX | Vaxcyte, Inc. | AGRANT | 10,681 | — | — | +78.9% | Open the original filing on SEC.gov |
| Dec 23, 2025 | PCVX | Vaxcyte, Inc. | GGIFT | 1,000 | — | — | -6.9% | Open the original filing on SEC.gov |
| Dec 23, 2025 | PCVX | Vaxcyte, Inc. | SSELL | 6,716 | $47.94 | $321.9K | -31.6% | Open the original filing on SEC.gov |
| Dec 23, 2025 | PCVX | Vaxcyte, Inc. | SSELL | 4,907 | $47.90 | $235K | -18.8% | Open the original filing on SEC.gov |
| Sep 8, 2025 | PCVX | Vaxcyte, Inc. | FTAX | 482 | $32.41 | $15.6K | -1.8% | Open the original filing on SEC.gov |
| Sep 7, 2025 | PCVX | Vaxcyte, Inc. | AGRANT⚠ | 2,810 | — | — | +11.5% | Open the original filing on SEC.gov |
| Sep 2, 2025 | PCVX | Vaxcyte, Inc. | FTAX | 325 | $31.56 | $10.3K | -1.2% | Open the original filing on SEC.gov |
| Sep 2, 2025 | PCVX | Vaxcyte, Inc. | FTAX | 242 | $31.56 | $7.6K | -0.9% | Open the original filing on SEC.gov |
| Aug 29, 2025 | PCVX | Vaxcyte, Inc. | AGRANT◆ | 9,743 | — | — | — | Open the original filing on SEC.gov |